139 related articles for article (PubMed ID: 9789710)
1. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.
Wikell C; Bergqvist PB; Hjorth S; Apelqvist G; Björk H; Bengtsson F
Clin Neuropharmacol; 1998; 21(5):296-306. PubMed ID: 9789710
[TBL] [Abstract][Full Text] [Related]
2. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.
Wikell C; Kugelberg FC; Hjorth S; Apelqvist G; Bengtsson F
Clin Neuropharmacol; 2001; 24(6):324-33. PubMed ID: 11801807
[TBL] [Abstract][Full Text] [Related]
3. Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
Wikell C; Apelqvist G; Hjorth S; Kullingsjö J; Bergqvist PB; Bengtsson F
Eur Neuropsychopharmacol; 2002 Aug; 12(4):327-36. PubMed ID: 12126872
[TBL] [Abstract][Full Text] [Related]
4. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy.
Apelqvist G; Wikell C; Carlsson B; Hjorth S; Bergqvist PB; Ahlner J; Bengtsson F
Clin Neuropharmacol; 2000; 23(6):304-17. PubMed ID: 11575864
[TBL] [Abstract][Full Text] [Related]
5. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F
Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy.
Bergqvist PB; Hjorth S; Apelqvist G; Bengtsson F
Metab Brain Dis; 1996 Sep; 11(3):269-78. PubMed ID: 8869946
[TBL] [Abstract][Full Text] [Related]
7. Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
Apelqvist G; Wikell C; Hindfelt B; Bergqvist PB; Andersson G; Bengtsson F
Psychopharmacology (Berl); 1999 Apr; 143(4):408-16. PubMed ID: 10367559
[TBL] [Abstract][Full Text] [Related]
8. Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy.
Bergqvist PB; Hjorth S; Apelqvist G; Bengtsson F
Metab Brain Dis; 1997 Sep; 12(3):193-202. PubMed ID: 9346468
[TBL] [Abstract][Full Text] [Related]
9. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Murrell MD; Cruz DA; Javors MA; Thompson PM
J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
[TBL] [Abstract][Full Text] [Related]
10. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
[TBL] [Abstract][Full Text] [Related]
11. Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
Bergqvist PB; Vogels BA; Bosman DK; Maas MA; Hjorth S; Chamuleau RA; Bengtsson F
J Neurochem; 1995 Mar; 64(3):1238-44. PubMed ID: 7532208
[TBL] [Abstract][Full Text] [Related]
12. Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
Kugelberg FC; Apelqvist G; Wikell C; Bengtsson F
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):155-61. PubMed ID: 16128909
[TBL] [Abstract][Full Text] [Related]
13. Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
Wikell C; Eap CB; Josefsson M; Apelqvist G; Ahlner J; Baumann P; Bengtsson F
Chirality; 2002 May; 14(4):347-50. PubMed ID: 11968077
[TBL] [Abstract][Full Text] [Related]
14. Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
Wikell C; Hjorth S; Apelqvist G; Kullingsjö J; Lundmark J; Bergqvist PB; Bengtsson F
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):448-55. PubMed ID: 11330339
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
16. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
18. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo.
Bergqvist PB; Hjorth S; Audet RM; Apelqvist G; Bengtsson F; Butterworth RF
Eur Neuropsychopharmacol; 1996 Nov; 6(4):317-22. PubMed ID: 8985716
[TBL] [Abstract][Full Text] [Related]
19. Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.
Franklin M; Clement EM; Campling G; Cowen PJ
J Psychopharmacol; 1998; 12(4):371-4. PubMed ID: 10065911
[TBL] [Abstract][Full Text] [Related]
20. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
